Indole-fused spirochromenes as potential anti-tubercular agents: design, synthesis and in vitro evaluation
- PMID: 32474889
- DOI: 10.1007/s11030-020-10108-z
Indole-fused spirochromenes as potential anti-tubercular agents: design, synthesis and in vitro evaluation
Abstract
As part of an ongoing effort to develop new anti-tubercular agents, a series of novel indole-fused spirochromene hybrids (7a-l) were efficiently synthesized in excellent yields by the popular 'Fisher-Indole synthesis' approach. The structure elucidation of the target compounds was carried out by different spectral techniques including 1H-NMR, 13C-NMR, ESI Mass, and FTIR analysis. Additionally, the proposed structure of 7i was proved by single-crystal X-ray analysis. These compounds (7a-l) were screened for in vitro anti-tubercular activity against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain. The results showed that most of the targets exhibited promising antimycobacterial activity with MICs of 1.56-6.25 μg/mL and weak cytotoxicity (19.93-32.16% at 50 μg/mL). Among them, compound 7l was found to be the most active compound (MIC of 1.56 μg/mL) with a good safety profile (32.16% at 50 μg/mL).
Keywords: Indole; Indole-fused spirochromene; Mycobacterium tuberculosis; Spirochromene; X-ray crystal.
© 2020. Springer Nature Switzerland AG.
Similar articles
-
Design of novel dispirooxindolopyrrolidine and dispirooxindolopyrrolothiazole derivatives as potential antitubercular agents.Bioorg Med Chem Lett. 2015 Oct 1;25(19):4308-13. doi: 10.1016/j.bmcl.2015.07.069. Epub 2015 Jul 26. Bioorg Med Chem Lett. 2015. PMID: 26271585
-
A regio- and stereoselective 1,3-dipolar cycloaddition for the synthesis of novel spiro-pyrrolothiazolyloxindoles and their antitubercular evaluation.Eur J Med Chem. 2010 Dec;45(12):5653-61. doi: 10.1016/j.ejmech.2010.09.019. Epub 2010 Sep 17. Eur J Med Chem. 2010. PMID: 20932607
-
Microwave-Assisted ZrSiO2 Catalysed Synthesis, Characterization and Computational Study of Novel Spiro[Indole-Thiazolidines] Derivatives as Anti-tubercular Agents.Interdiscip Sci. 2018 Jun;10(2):411-418. doi: 10.1007/s12539-016-0195-2. Epub 2016 Nov 11. Interdiscip Sci. 2018. PMID: 27837427
-
Synthesis and antitubercular activity of amino alcohol fused spirochromone conjugates.Bioorg Med Chem Lett. 2013 Mar 1;23(5):1416-9. doi: 10.1016/j.bmcl.2012.12.073. Epub 2013 Jan 5. Bioorg Med Chem Lett. 2013. PMID: 23357635
-
Indole: A promising scaffold for the discovery and development of potential anti-tubercular agents.Curr Res Pharmacol Drug Discov. 2022 Jul 16;3:100119. doi: 10.1016/j.crphar.2022.100119. eCollection 2022. Curr Res Pharmacol Drug Discov. 2022. PMID: 35992375 Free PMC article. Review.
Cited by
-
An insight into the recent developments in anti-infective potential of indole and associated hybrids.J Mol Struct. 2022 Aug 5;1261:132808. doi: 10.1016/j.molstruc.2022.132808. Epub 2022 Mar 11. J Mol Struct. 2022. PMID: 35291692 Free PMC article. Review.
-
Spirocyclic compounds: potential drug leads in the fight against Mycobacterium tuberculosis.Future Med Chem. 2025 Apr;17(7):819-837. doi: 10.1080/17568919.2025.2479413. Epub 2025 Mar 19. Future Med Chem. 2025. PMID: 40103373 Review.
-
Design, synthesis, anti-mycobacterial activity, molecular docking and ADME analysis of spiroquinoxaline-1,2,4-oxadiazoles via [3 + 2] cycloaddition reaction under ultrasound irradiation.Mol Divers. 2024 Dec;28(6):3979-3991. doi: 10.1007/s11030-023-10790-9. Epub 2024 Jan 23. Mol Divers. 2024. PMID: 38261121
References
-
- World Health Organization, Global tuberculosis report 2019. https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-en... . Accessed 14 Oct 2019
-
- World Health Organization, Global tuberculosis report, 2013. http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf
-
- Kaufmann SHE, Rubin E (2008) Handbook of tuberculosis: clinics, diagnostics, therapy and epidemiology. Wiley, Hoboken - DOI
-
- Espinal MA (2003) The global situation of MDR-TB. Tuberculosis 83:44–51. https://doi.org/10.1016/s1472-9792(02)00058-6 - DOI - PubMed
-
- Lienhardt C, Raviglione M, Spigelman M, Hafner R, Jaramillo E, Hoelscher M, Zumla A, Gheuens J (2012) New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future. J Infect Dis 205:S241–S249. https://doi.org/10.1093/infdis/jis034 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials